NEA Management Company
NEA Management Company reported 26 stocks worth $1.6B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are TRVI (15.5%), MBX (12.6%) and GLUE (11.7%). Compared with Q1 2026, the fund opened new positions in KPTI and trimmed CELC and CVRX.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() TRVI Trevi Therapeutics Inc | $247M | 15.5% | 13.2M | No change | 8 of 8 | |
| 2 | ![]() MBX Mbx Biosciences Inc | $200M | 12.6% | 3.6M | No change | 8 of 8 | |
| 3 | ![]() GLUE Monte Rosa Therapeutics Inc | $186M | 11.7% | 7.7M | No change | 8 of 8 | |
| 4 | ![]() CELC Celcuity Inc | $179M | 11.3% | 1.7M | −575K (−25%) | 8 of 8 | |
| 5 | ![]() SGP Spyglass Pharma Inc | $165M | 10.4% | 7.4M | No change | 2 of 8 | |
| 6 | ![]() SVRA Savara Inc | $151M | 9.5% | 24.5M | No change | 8 of 8 | |
| 7 | ![]() ZBIO Zenas Biopharma Inc | $102M | 6.4% | 4M | No change | 8 of 8 | |
| 8 | ![]() COUR Coursera Inc | $72.6M | 4.6% | 12.9M | No change | 8 of 8 | |
| 9 | ![]() AUPH Aurinia Pharmaceuticals Inc | $67.4M | 4.2% | 4M | No change | 8 of 8 | |
| 10 | ![]() CRSP Crispr Therapeutics | $57.7M | 3.6% | 1.1M | No change | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
ARCELLX INC | $350M | 3M |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →NEA Management Company 13F FAQ
What does NEA Management Company own?
NEA Management Company reported 26 stocks worth $1.6B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are TRVI (15.5%), MBX (12.6%) and GLUE (11.7%). The table above lists every position in the filing (the top 10 without an account).
What did NEA Management Company buy and sell in Q2 2026?
Compared with Q1 2026: 1 new positions, 0 added to, 2 trimmed and 1 sold out. New positions include KPTI.
When will NEA Management Company file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is NEA Management Company's portfolio worth?
The Q2 2026 filing reports $1.6B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.









